2 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
5 Jun 23
Current report (foreign)
4:28pm
life quality index; SD=standard deviation. aRepresents the primary analysis population. Demographics represent patients with moderate-to-severe AD … Endpoints Change from baseline in modified/adapted Mayo Score at Week 12 in 0.2 mg icanbelimod group versus placebo
Demographics & Characteristics
6-K
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
3 May 22
Connect Biopharma Announces Week 12 Top-Line Results from Phase 2 CBP-307 Trial in Patients with Moderate-to-Severe Ulcerative Colitis
4:36pm
***Responders at Week 12 without clinical response at Week 24 are withdrawn from treatment
Demographics & Characteristics CBP-307 0.1 mg PO QD (n=39) CBP … (1.3) Failed TNF treatment, n (%) 1 (2.6) 2 (3.8) 2 (3.8) Baseline demographics and characteristics were generally well balanced across the treatment
- Prev
- 1
- Next